Spectrum to develop cancer drug apaziquone with Handok

11/23/2009 | Reuters

Spectrum Pharmaceuticals agreed to co-develop and market its cancer drug candidate apaziquone with South Korea's Handok Pharmaceuticals. The product is in late-stage clinical trials in patients with nonmuscle invasive bladder cancer.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT